chrisvoncsefalvay/vaers-outcomes huggingface dataset:
hospitalized after receiving her flu shot / within hours she could not breath / admitted to the hospital for approximately 24 hours; hospitalized after receiving her flu shot / within hours she could not breath / admitted to the hospital for approximately 24 hours; This case was reported by a consumer via call center representative and described the occurrence of asthmatic attack in a adult female patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   Previously administered products included Flu vaccine with an associated reaction of dyspnoea (received on an unknown date 7 or 8 years prior to reporting date and also experienced asthma attack, refer case US2021129095). Concomitant products included budesonide + formoterol fumarate (Symbicort) and ipratropium + salbutamol (Albuterol And Ipratropium Nebule).   On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season. On an unknown date, less than a day after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced asthmatic attack (serious criteria hospitalization) and difficulty breathing (serious criteria hospitalization). The patient was treated with steroids nos (Steroids). Rechallenge with Influenza vaccine Quadrivalent unspecified season was positive. On an unknown date, the outcome of the asthmatic attack and difficulty breathing were recovered/resolved.   It was unknown if the reporter considered the asthmatic attack and difficulty breathing to be related to Influenza vaccine Quadrivalent unspecified season.  Additional details were reported as follows: This case was reported by patient herself via an outbound call for the Program. The age at vaccination was not reported but could be 58 or 59 years. Concomitant products included rescue inhaler and oral steroids (unspecified). 3 years prior the reporting date, the patient received flu vaccine and within hours she could not breath and was admitted to the hospital for approximately 24 hours and given steroids. The patient stated that the hospitalization was for asthma attack. The patient's symptoms resolved by the time she was discharged from the hospital. The patient had elected not to take Nucala due to the cost and stated she did not trust injections in general as she had twice been hospitalized after receiving her flu shot.  The patient consented to follow up with her physician The reporter consented to follow-up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021129095:same reporter
Received 1.0ml of flu vaccine. Increased pain and discomfort at injection site more than she usually experiences. She states gets the flu shot every year. Complained of mottling at site. Sore arm for 4 days.
Sat - body weakness, sore throat & headache (pounding), nausea. Sun - body weakness, fever (slight). Mon - body weakness, fever, congestion, sore throat. Tues - mild headache, weakness.
Mom reports that after pt's last of vaccines that she developed a spasm type reaction with her arms. Mom concerned that it may be like a seizure.   Mom reports that when pt was a baby and received her first round of vaccines that she noticed pt would hold her hand to her chest and her arms would tremor. The tremor faded away, then returned with her next round of vaccines. At first mom suspected she was purposefully doing it to be playful. Mom reports after the second round of vaccines that the tremor became more jerky and it seemed to be painful and uncontrollable. Mom was concerned and did not vaccinate her for the next year. She reports the tremors/spasms resolved.    After her latest round of vaccines on 06/14/2019, the spasms returned. The latest episode was about 2 days ago.
This spontaneous report as received from a medical assistant refers to unspecified patients of unknown age and gender. The patient's pertinent medical history, current conditions and concomitant medications were not reported. On an unknown date the patients were vaccinated with improperly stored ROTATEQ (dosing details were not reported) (lot # M025565, expiry date: 06-NOV-2017) orally. No adverse effects were reported. There was no product quality complaint involved. This is one of the two reports received from the same reporter. Additional information has been requested.
reports that 2 days after shot, she developed hives all over her body and has no known allergies
no symptoms or additional adverse effects; patient recevied unspecifed dose in Gardasil 9 immunization series was administered after being improperly stored; This spontaneous report was received from a medical assistance and refers to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions, allergies and concomitant medication were not reported.  On 02-JUN-2020, the patient was vaccinated with a improperly stored dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) lot # 1614898, expiration date reported as 14-NOV-2021, but upon internal validation established as 15-NOV-2021 for prophylaxis (exact dose, dose #, route of administration and anatomical location were not provided). The temperature excursion was 28.8 degrees Fahrenheit (F) for 5 minutes. There were no previous excursions reported. The digital data logger was involved. No symptoms or additional adverse effects were reported. combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: 1614898; expirationdate: 15-NOV-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Unknown; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability
Client reports feeling light headed and nauseous. He was advised to sit and take small sips of apple juice and water as tolerated. Client reportedly had two episodes of emesis ranging   15-20 minutes  apart. received verbal orders to adminsiter benadryl. Client was unable to keep tolerate and vomitted 12-15 minutes later. Client was then transported to Urgent care facility.
Approximately 15 hours after each dose, I've received 5, I started to experience stomach pains. I had an endoscopy completed and they found that I had Gastroenteritis. I have never had stomach pains like before I received the COVID vaccines. I had biopsies completed, but the physicians have not been able to find anything. The doctor was talking about treating me with a steroid before and after any new COVID vaccines I may receive. Also, about four weeks after receiving the fifth dose, I had a shingles outbreak. It was a mild outbreak, so I was not prescribed any medications. I have recovered from shingles, but my stomach has never been the same.
Swelling in throat itching on my cheek and hand swelling on my left lymph gland in neck.   everything was on my left side, Developed an inch round spot close to my eye showed up on Sunday and its red. Did run a slight fever went up to 100.1 and chills. arm pain that lasted a couple of days. Everything has been on the left side.
This spontaneous report was received from a registered nurse and refers to a 4 month old female patient. The patient had no concomitant medications and no drug reactions or allergies. On 21-JUN-2016, the patient was vaccinated with oral ROTATEQ oral solution, lot # reported as L046319, expiry date 28-SEP-2017 (dose was not specified). Other suspect therapies included DTaP, Hib, poliovirus vaccine and PREVNAR, administered on the same day. On 21-JUN-2016, the patient instantaneously vomited after receiving oral ROTATEQ. The patient sought medical attention in the office, at the time of the event. No treatment was given. No lab diagnostics were performed. The outcome of the event and the causality assessment were not specified. This is one of several reports received from the same reporter. Additional information has been requested.
all of my joints hurt, chills, extreme fatigue.  Shot on thursday, symptoms still present on tuesday.  Like when I was in chemo.  able to move around slowly and for short periods.  I am sure this will go away, but it has taken several days already.
Feeling heart palpitations and heaviness in chest throughout the day. Started possibly 7-10 days post-vaccine. Did not associate it with the vaccine until I read about heart complications in younger age group.
Mom called stated Pt had started getting a rash to both legs, mom informed to bring back to clinic, then mom called and stated he was getting swollen to face and went to ER. Tried calling Mom no answer
anaphylactic shock; facial swelling significantly increased; A spontaneous report was received from a consumer concerning a female patient(unknown age), who received Moderna's covid-19 vaccine(mRNA-1273) and experienced anaphylactic shock and facial swelling.  Patient's medical history was not provided. No relevant concomitant medications were mentioned.  On 29 Jan 2021, one day prior to the onset of events, patient received mRNA-1273 vaccine(Lot number:unknown) for prophylaxis of covid-19 infection.  On 30 Jan 2021, around 3:30pm, patient started experiencing swelling of face. By 5:00 pm, she went into complete anaphylactic shock and was hospitalized. Lab investigations included high WBC, high absolute neutrophil, high absolute monocytes and low carbon dioxide.   Treatment medications included two injections of epinephrine(Adrenalin),two injections of diphenhydramine(Benadryl),an injection of methylprednisolone(SOLU-Medrol),an injection of Famotidine(Pepcid),one litre of sodium chloride(Normal saline),and Acetaminophen(Tylenol).She was discharged with an EpiPen and another prescription of Prednisone(20mg).  Action taken with mRNA-1273 in response to the event was not reported.  Outcome of the event, anaphylactic shock was not reported, whereas, the outcome of facial swelling was considered not resolved.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Felt warm and arm sore the evening of the vaccination. Woke up dizzy and nauseous, no vomiting.
After second shot: High fever over 102, chills, cold sweats, nausea, vomiting, body aches  Tylenol and Motrin  High fever lowered to low grade fever, which continued for an additional two days. Most side effects ameliorated after day three. Body aches continue.
Shingles two days after 1st dose; This case was reported by a consumer via call center representative and described the occurrence of shingles in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (had a history of shingles for several years).   On 18th August 2021, the patient received the 1st dose of Shingrix .5 ml. In August 2021, 2 days after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The case was reported by the consumer for herself. The patient stated that, got her first vaccine of Shingrix on Wednesday at the time of reporting. The patient said that, two days later she had an outbreak of shingles. The reporter did not consent to follow up.
Fever, chills, extreme muscle aches, headaches, nausea, extreme fatigue and a 12 day period, and inner body trimmer.
temperature excursion on GARDASIL 9; No other adverse events - No signs or symptoms reported; Information has been received from a registered nurse reporting on a patient of unknown age and gender. There was no information about the patient's concurrent conditions, medical history or concomitant medication.  On an unknown date, the patient was vaccinated with an improperly stored dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) 0.5 mL for prophylaxis, lot# 1687293 and expiration date reported as 25-AUG-2022, but upon internal validation was established as 30-APR-2023 (route of administration not reported). No adverse events were reported.  On an unknown date, the vaccine underwent a temperature excursion of 47.1 Fahrenheit degree for 13 minutes. No previous temperature excursions were reported. The call was not placed because a digital data logger.  This is one of several reports received from the same reporter. combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: 1687293; expirationdate: 30-APR-2023; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability; Sender's Comments:  US-009507513-2103USA005285: US-009507513-2104USA003211: US-009507513-2104USA003212: US-009507513-2104USA003213: US-009507513-2104USA003214: US-009507513-2104USA003215: US-009507513-2104USA003216: US-009507513-2104USA003217: US-009507513-2104USA003218: US-009507513-2104USA003219: US-009507513-2104USA003220: US-009507513-2104USA003221: US-009507513-2104USA003222: US-009507513-2104USA003223: US-009507513-2104USA003224: US-009507513-2104USA003225: US-009507513-2104USA003196: US-009507513-2104USA003197: US-009507513-2104USA003198: US-009507513-2104USA003199: US-009507513-2104USA003200: US-009507513-2104USA003201: US-009507513-2104USA003202: US-009507513-2104USA003204: US-009507513-2104USA003205: US-009507513-2104USA003206: US-009507513-2104USA003210: US-009507513-2104USA003207: US-009507513-2104USA003208: US-009507513-2104USA003209:
nausea/ Dizziness with in 10 minutes of vaccine. Flushing and Tingling in face and upper extremities. Patient had Covid in November. She went home to rest after the vaccination.
Sore arm never got better and in fact got worse over time. Difficulty lifting, pushing, carrying, raising arm over shoulder. Still causing discomfort after 6 weeks. Went to dr. and diagnosed rotator cuff tendinitus as a result of poorly placed injection of needle. Just started PT this week.
Tested positive for COVID-19; This spontaneous case was reported by an other health care professional and describes the occurrence of COVID-19 (Tested positive for COVID-19) in an 8-month-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AS1417B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 18-Jan-2023, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 30-Jan-2023, the patient experienced COVID-19 (Tested positive for COVID-19). At the time of the report, COVID-19 (Tested positive for COVID-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-Jan-2023, SARS-CoV-2 test: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications details were reported. Chronic or long standing health conditions and acute illnesses at the time of vaccination and up to one month before was none. Prescription, over the counter medication, dietary supplements or herbal remedies being taken at time of vaccination and/or at the tine of the adverse event was none. No treatment medications details were reported.   This case was linked to MOD-2023-711261 (Patient Link).
Information has been received from a physician concerning an infant patient, who on an unspecified date, was vaccinated with a dose of ROTATEQ (dose, route and Lot# not specified). The physician reported that "2-3 weeks" after the patient was given the dose of ROTATEQ (dates unspecified), patient experienced blood in stool. The physician also reported that the patient had poor weight gain. At the time of the report the patient's outcome, was not reported. It was unspecified if the patient sought medical attention. This is one of several reports from the same source. All telephone attempts to obtain follow-up information have been unsuccessful. Additional information has been requested.
Persistent heavy cough, tiredness, waking up short of breath, difficult to breath when exerting, soreness and muscle pain, fatigue and lack of endurance, depression,
Approx 10 minutes after getting HPV #2, pt's eyes began to water severely. Approx 5 minutes after that, pt had severe headache, nausea, dizziness, clammy hands, blurry vision. After a larger dose of BENADRYL at the ER, pt started to feel better. Pt does have a lingering headache but the other symptoms have resolved.
Pt vaccinated with DTP experienced red and swollen abscess vs tender to the touch local rxs; some difficulty walking 12CM X 8CM
Information has been received from a lawyer regarding a case in litigation concerning a male patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. On or about 15-JUN-2016, the patient was vaccinated with ZOSTAVAX, (lot # and route unknown) for routine adult health maintenance and for the long-term prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster or shingles. Later in 2016, the patient was treated by a physician for a vesicular outbreak, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Information has been received from a registered nurse concerning a male who, on an unspecified date, was vaccinated with 0.65 ml of ZOSTAVAX.  It was reported that the patient developed shingles (date unspecified) after receiving ZOSTAVAX.  Unspecified medical attention was sought.  There was no product quality complaint.  Additional information has been requested. This is in follow-up to report(s) previously submitted on 3/26/2008. Information has been received from a physician concerning a 70 year old male with no pertinent medical history, drug reactions, or allergies who in 2007 was vaccinated with a first dose, into the right deltoid, with a 0.65 ml of ZOSTAVAX (Merck) (lot # 652966/0722F). There was no illness at the time of vaccination. It was reported that in February 2008 the patient developed Herpes Zoster (date unspecified). Unspecified medical attention was sought. At the time of reporting the patient was recovered (date unspecified). There was no product quality complaint. Additional information is not expected.
This initial spontaneous case, was received from a physician on 07-Nov-2017, concerning a 35-year-old male adult patient. The current conditions included ADD (attention deficit disorder), high blood pressure controlled with diet. The concomitant medications included, ibuprofen and trazodone 50 mg (as reported) for unknown indications. On 07-Nov-2017, the patient administered with FLUCELVAX QIV (dose: 1.5 ml (as reported), route of administration: intramuscular, anatomical location: left deltoid, batch number: 195128, expiry date: Apr-2018) (explicitly coded as extra dose administered). No adverse event was reported. The reporter assessed this case as non-serious.
On May 15th, she got the J&J vaccine.  Then on May 17th, while she was walking, she tripped on a curb and fell and then landed on her left knee.  Then, this past Thursday on May 20th, she noticed swelling and pain in the left leg.  She presented to urgent care the following day on Friday and had an ultrasound done that revealed blood clot in the superficial veins.  Patient recalls of had a similar episode of superficial vein clot about 6 years ago. Referred to vascular and second ultrasound done revealing DVT
One week (7 days) after receiving the first dose of the Moderna vaccine, I noticed a hot, itchy hard lump at the injection site. The rash gradually grew over the next 5-6 days. The hard, painful lump lasted about 4 days. It is now 6 days after the rash developed and 13 days after I received the vaccine. The rash is still hot and itchy. The area of the rash is 6.5 inches tall and 3.5 inches wide. I have not received any treatment or take any over the counter medication.
Per patient report / description:  "The day after the shot I had a lot of arthritic type pain all over my body for two days then continuing pain until now 5/14/21.  I cannot walk more than a block, cannot stand for more than 5-10 minutes, Lingering pain all the time."  Called PCP with this report:  " adverse reaction to my Pfizer 2nd shot.  The next day after the shot it seemed like the vaccine searched out every part of my body that might/might not have arthritis and moving was very difficult for two days.  Thereafter I have had a great difficulty getting up in the morning, some days better than others.  I have seen (chiropractor) often, but results have not cleared up the discomfort.  I cannot walk more than a block without discomfort, cannot sit unless my feet are up for great amounts of time then expect to be able to move.  Is there something that you could prescribe that would give me comfort and be able to walk without pain.  I am not interested in anything that would be considered an opioid, would rather go without.  Currently I am taking Excedrin.  Someone told me that Advil would be better for arthritis, but I had a bad headache on day two of taking that."  Told to scheduled appointment with PCP for evaluation.
Mother reported at approximately 3:30pm 02/12/04 that child vomited during night.  Denied fever or rash.  Said baby felt hot but was given Tylenol regularly.  Stated she was better after having been sick.  Reports baby sitter called--reported infant vomited a lot of mucusy vomit.  Denied fever or rash.  Called am 2/13 and stated baby developed fever and trembling.  No seizure.  Taken to Dr. --'s office and temp was 103.8 and NP treated with pherergan 5mg suppository.  Temp down to 102.3 at Dr's office.  Later that morning child fussy but keeping liquids down and no diarrhea.  Call to Dr's office -- NP also felt that illness not associated to vaccines except fever.
about 1 wk p/the vax pt devel low grade fever; parents said felt warm but did not take temp; pt devel a rash about 10 days p/vax was given; also has had a runny nose during this time period;
Patient scheduled appt. for 3 shots. When he came in he sad that he didn't have any live vaccines in last 4 weeks and these were primary doses. Afterwards, realized he received MMR 1 week to early
Headache, Myalgia, Fever, FEVER HEADACHE, RESTLESSNESS, MUSCLE ACHES, NAUSEA Narrative: